Evidence map›Paper›PMID 29621669›Full record

ReviewThe Journal of nutritional biochemistry2018

Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.

Kembra Albracht-Schulte, Nishan Sudheera Kalupahana, Latha Ramalingam, Shu Wang, Shaikh Mizanoor Rahman, Jacalyn Robert-McComb, Naima Moustaid-Moussa

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The Journal of nutritional biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04901052 (Effect of a Diet Supplemented With Omega-3 on Biochemical Variables, Cytokine Concentration and Fatty Acid Profile in Subjects With Obesity), which is not on this map. Cited by 172 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 3 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04901052 nacompletednot on this map

Effect of a Diet Supplemented With Omega-3 on Biochemical Variables, Cytokine Concentration and Fatty Acid Profile in Subjects With Obesity

TypeinterventionalSponsorUniversity of GuadalajaraRan2018 to 2019Enrolled58ConditionsObesityArmsn-3 supplementation group, Placebo group
3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 3 syntheses or guidelines pooled it, 337 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Marine Oil fromNutrients · 2022
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kembra Albracht-SchulteDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA.
Nishan Sudheera KalupahanaDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA; Department of Physiology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. Electronic address: skalupahana@pdn.ac.lk.
Latha RamalingamDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA.
Shu WangDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA.
Shaikh Mizanoor RahmanDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA.
Jacalyn Robert-McCombObesity Research Cluster, Texas Tech University, Lubbock, TX, USA; Department of Kinesiology, Texas Tech University, Lubbock, TX, USA.
Naima Moustaid-MoussaDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA; Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA. Electronic address: naima.moustaid-moussa@ttu.edu.
Texas Tech University · USUniversity of Peradeniya · LK

Funding

Anti-obesity effects of omega 3 fatty acids in brown adipose tissueR15AT008879 · NCCIH · TEXAS TECH UNIVERSITY · PI MOUSTAID-MOUSSA, NAIMA · 2016 to 2018
$799k
NCCIH NIH HHS R15 AT008879
6 · The paper itself

Abstract

Strategies to reduce obesity have become public health priorities as the prevalence of obesity has risen in the United States and around the world. While the anti-inflammatory and hypotriglyceridemic properties of long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) are well known, their antiobesity effects and efficacy against metabolic syndrome, especially in humans, are still under debate. In animal models, evidence consistently suggests a role for n-3 PUFAs in reducing fat mass, particularly in the retroperitoneal and epididymal regions. In humans, however, published research suggests that though n-3 PUFAs may not aid weight loss, they may attenuate further weight gain and could be useful in the diet or as a supplement to help maintain weight loss. Proposed mechanisms by which n-3 PUFAs may work to improve body composition and counteract obesity-related metabolic changes include modulating lipid metabolism; regulating adipokines, such as adiponectin and leptin; alleviating adipose tissue inflammation; promoting adipogenesis and altering epigenetic mechanisms.

Indexed as

Adipose TissueAnimalsAnti-Obesity AgentsBody CompositionExerciseFatty Acids, Omega-3HumansInsulin ResistanceMetabolic SyndromeObesityPanniculitisVegetablesAnti-Obesity AgentsFatty Acids, Omega-3AdipocytesFish oilMetabolic syndromeObesityOmega-3 polyunsaturated fatty acidsWeight loss

Identifiers

PMID29621669
PMCPMC7561009
OpenAlexW2792374913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.